Tags | Domains | Searches | Statistics | Options | Advanced Search
|
Tags | Domains | Searches | Statistics | Options | Advanced Search |
Know More Media - Health Care / Pharmaceutical / Fitness - Jul 25, 2008
The U.S. Food and Drug Administration has granted a six month pediatric exclusivity to Ortho-McNeil-Janssen Pharmaceuticals for its drug Topamax for use in patients aged 1 to 24 months with partial onset seizures. The …
PharmaGazette - Jul 25, 2008
The U.S. Food and Drug Administration has granted a six month pediatric exclusivity to Ortho-McNeil-Janssen Pharmaceuticals for its drug Topamax for use in patients aged 1 to 24 months with partial onset seizures. The …
PharmaGazette - Jul 14, 2008
The U.S. Food and Drug Administration announced that it has revised its method of communicating that a drug cannot be approved as submitted to pharmaceutcial companies. Previously the FDA's Center for Drug Evaluation …
Know More Media - Health Care / Pharmaceutical / Fitness - Jul 14, 2008
The U.S. Food and Drug Administration announced that it has revised its method of communicating that a drug cannot be approved as submitted to pharmaceutcial companies. Previously the FDA's Center for Drug Evaluation …
PharmaGazette - Jun 30, 2008
GlaxoSmithKline (NYSE: GSK ) announced that it has submitted its response to the U.S. Food and Drug Administration to questions the agency had in response to GSK's drug application for Cervarix. Cervarix, a vaccine …
Also tagged: gsk, fda, r, cervical cancer, cervarix
Know More Media - Health Care / Pharmaceutical / Fitness - Jun 30, 2008
GlaxoSmithKline (NYSE: GSK ) announced that it has submitted its response to the U.S. Food and Drug Administration to questions the agency had in response to GSK's drug application for Cervarix. Cervarix, a vaccine …
Also tagged: gsk, fda, r, cervical cancer, cervarix
PharmaGazette - Jun 25, 2008
The U.S. Food and Drug Administration has approved GlaxoSmithKline's combination booster vaccine, Kinrix. Kinrix protects children between 4 and 6 years old against diphtheria, pertussis, polio and tetanus and is …
Know More Media - Health Care / Pharmaceutical / Fitness - Jun 25, 2008
The U.S. Food and Drug Administration has approved GlaxoSmithKline's combination booster vaccine, Kinrix. Kinrix protects children between 4 and 6 years old against diphtheria, pertussis, polio and tetanus and is …
PharmaGazette - Jun 25, 2008
Eli Lilly & Co and Daiichi Sankyo announced the U.S. Food and Drug Administration had extended the period of review by three months for their anti-clotting drug, Prasugrel. Prasugrel received priority review …
Also tagged: fda, eli lilly, plavix, parasugrel, daiichi
Know More Media - Health Care / Pharmaceutical / Fitness - Jun 25, 2008
Eli Lilly & Co and Daiichi Sankyo announced the U.S. Food and Drug Administration had extended the period of review by three months for their anti-clotting drug, Prasugrel. Prasugrel received priority review …
Also tagged: fda, eli lilly, plavix, parasugrel, daiichi